Micafungin intermediate; CAS No.:179162-55-1

Micafungin intermediate;  

CAS No.:179162-55-1;

4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzoic acid

Boxiao Biopharmaceutical co., ltd., Founded in August,2020 located in National Economic and Technological Development Area,Xindeng Town, Fuyang District.It is a highly integrated innovative biopharmaceutical company co-founded by a group of drug workers with decades of medical background and rich practical experience.

Follow the business model of “research and developmet-small/pilot scale up-industrialization or industrial production ”. Boxiao Biopharmaceutical has built the Microbial Platform, Enzyme engineering platform, Green chemical Technological platform,New Drug Delivery Technology Platform, Multi-production line of Drugs and QC Platform. Moreover, supported with registration and publishing dept., clinical research dept., QA,QC, Intellectual property,information collection etc., to achieve synchronous development patterm of APIs and Preparations.

Boxiao Biopharmaceutical focused in use of synthetic biology into genetic modification of traditional fermentation strains and industrial intelligent manufacturing of cell factory.

Now,the company has completed the technology construction platform,which the wide range layout of products derived from. With the strategic position of integrating "specialty APIs (intermediates) + unique preparations" based in China and facing the global market, the company provides diversified services for multiple subdivided fields in the pharmaceutical industry, and provides innovative drugs and professional health solutions for the public,Boxiao Biopharmaceutical has becoming one of the most valuable and trustworthy  enterprises in China.